Felix Geissler

Geen lopende functies

Consumer Services

Health Technology

Electronic Technology

Oorsprong van het eerstegraads netwerk van Felix Geissler

Entiteit	Type entiteit	Industrie
CURIS, INC. 5	Public Company	Biotechnology	5

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Felix Geissler via zijn persoonlijke netwerk

Onderneming	Sector	Gelieerde personen	Hoofdpost
ABBOTT LABORATORIES	Medical Specialties	Anne Borgman	Corporate Officer/Principal
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Biotechnology	Lori Kunkel	Corporate Officer/Principal
MERCK & CO., INC.	Pharmaceuticals: Major	Diantha Duvall	Director/Board Member
PHARMACYCLICS, INC.	Pharmaceuticals: Major	Lori Kunkel	Chief Tech/Sci/R&D Officer
BIOGEN INC.	Pharmaceuticals: Major	Diantha Duvall	Corporate Officer/Principal
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Pharmaceuticals: Major	Lori Kunkel	Corporate Officer/Principal
CUBIST PHARMACEUTICALS INC	Pharmaceuticals: Major	William Steinkrauss	Corporate Officer/Principal
XOMA CORPORATION	Pharmaceuticals: Major	Lori Kunkel	Corporate Officer/Principal
EXELIXIS, INC.	Pharmaceuticals: Major	Anne Borgman	Corporate Officer/Principal
HUMANIGEN, INC.	Biotechnology	Anne Borgman	Chief Tech/Sci/R&D Officer
XENCOR, INC.	Biotechnology	Lori Kunkel	Chief Tech/Sci/R&D Officer
SUTRO BIOPHARMA, INC.	Pharmaceuticals: Major	Anne Borgman	Chief Tech/Sci/R&D Officer
GENOCEA BIOSCIENCES, INC.	Biotechnology	Diantha Duvall	Director of Finance/CFO
SYNDAX PHARMACEUTICALS, INC.	Biotechnology	Lori Kunkel	Chief Tech/Sci/R&D Officer
BioTheryX, Inc. BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.	Pharmaceuticals: Major	Diantha Duvall	Director/Board Member
Grifols, Inc. Grifols, Inc. Pharmaceuticals: MajorHealth Technology Grifols, Inc. manufactures pharmaceuticals. The company is headquartered in Los Angeles, CA.	Pharmaceuticals: Major	Kimberly Steinmann	Chief Tech/Sci/R&D Officer
NURIX THERAPEUTICS, INC.	Pharmaceuticals: Major	Lori Kunkel	Director/Board Member
University of Southern California University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.	College/University	Lori Kunkel	Doctorate Degree
Talon Therapeutics, Inc. Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.	Pharmaceuticals: Major	Anne Borgman	Corporate Officer/Principal
Boston College	College/University	William Steinkrauss	Graduate Degree
Colby College	College/University	Diantha Duvall	Undergraduate Degree
The University of Chicago	College/University	Anne Borgman	Corporate Officer/Principal
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.	College/University	Diantha Duvall	Graduate Degree
St. Louis University	College/University	Kimberly Steinmann	Doctorate Degree
University of California San Diego	College/University	Lori Kunkel	Undergraduate Degree
University of Illinois	College/University	Anne Borgman	Undergraduate Degree
DNAX Research, Inc.		Lori Kunkel	Corporate Officer/Principal
ACT Biotech, Inc. ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY.	Pharmaceuticals: Major	Lori Kunkel	Chief Tech/Sci/R&D Officer
University of California	College/University	Lori Kunkel	Corporate Officer/Principal
JAZZ PHARMACEUTICALS PLC	Pharmaceuticals: Major	Anne Borgman	Corporate Officer/Principal
LOXO ONCOLOGY INC	Pharmaceuticals: Major	Lori Kunkel	Chief Tech/Sci/R&D Officer
Amphivena Therapeutics, Inc. Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.	Drugstore Chains	Lori Kunkel	Director/Board Member
Stritch School of Medicine	College/University	Anne Borgman	Doctorate Degree
ORIC PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Lori Kunkel	Director/Board Member
NEXTCURE, INC.	Pharmaceuticals: Major	Anne Borgman	Director/Board Member
HARPOON THERAPEUTICS, INC.	Biotechnology	Lori Kunkel	Director/Board Member
BIOVERATIV INC	Biotechnology	Diantha Duvall	Comptroller/Controller/Auditor
Maverick Therapeutics, Inc. Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA.	Biotechnology	Lori Kunkel	Director/Board Member
Lak505, LLC		Lori Kunkel	Corporate Officer/Principal
NiKang Therapeutics, Inc. NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE.	Biotechnology	Anne Borgman	Director/Board Member
K36 Therapeutics, Inc. K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly.	Pharmaceuticals: Major	Lori Kunkel	Director/Board Member
ENLIVEN THERAPEUTICS, INC.	Biotechnology	Lori Kunkel	Director/Board Member
Kalobios Pharmaceuticals, Inc.		Anne Borgman	Corporate Officer/Principal